BioMed Research International

Cytotoxic T Lymphocytes and Vaccine Development


Publishing date
01 Jun 2010
Status
Published
Submission deadline
01 Dec 2009

Lead Editor

1Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA

2Department of Cellular Biology, University of Georgia, Athens, GA 30602, USA

3Department of Infectious Disease, School of Veterinary Medicine China Agricultural University, Beijing 100094, China


Cytotoxic T Lymphocytes and Vaccine Development

Description

As one of the major players in adaptive immunity, cytotoxic T Lymphocytes (CTLs) play a critical role in the control of many infections and cancers. More importantly, induction of long-lasting functional CTLs has become a goal for the modern vaccination, especially for chronic infectious diseases. However, to achieve this goal, CTLs have to be appropriately activated and programmed. The molecular mechanisms of CTL activation are just starting to be understood and have been shown to be related to antigenic stimulation, expression of distinct costimulatory molecules, and inflammatory cytokines. In addition, provision of these stimuli may differ with distinct infections due to the tissue-specificity of the pathogen, chronicity or persistence of antigen, differences in antigen presentation, and/ or the cytokine milieu. By increasing our overall understanding of how these factors modulate CTL responses, we can design multifaceted vaccines which augment the development of functional, long-lasting memory CTLs in addition to neutralizing antibodies.

We invite authors to present original research articles as well as review articles that will stimulate the continuing efforts in defining the factors involved in CTL activation and the development of immunological memory. We are particularly interested in manuscripts that report the molecular mechanisms required for the development of effector and memory CTLs, CTL responses in specific infections in animals and humans, test different strategies of memory CTL induction, and reports of new assays to evaluate CTL function. Reviews that summarize the results of latest discoveries and their implications on vaccination in economically important animals, the regulation of CTL responses by immune cells such as dendritic cells, CD4 and regulatory cells, as well as molecular mechanisms of CTL killing function are particularly welcome. Potential topics include but are not limited to:

  • Molecular mechanisms of CTL activation and programming
  • Signal transduction for CTL migration
  • Regulation of CTL induction and function by regulatory cells
  • Molecular and epigenetic mechanisms of functional memory T cell development
  • Characterization of CTL responses in infections in animals and humans
  • Novel vaccine approaches for the induction of functional memory CTLs
  • New assays for the evaluation of CTL activation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jbb/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 764542
  • - Review Article

Induction of Specific CD8+ T Cells against Intracellular Bacteria by CD8+ T-Cell-Oriented Immunization Approaches

Toshi Nagata | Yukio Koide
  • Special Issue
  • - Volume 2010
  • - Article ID 218752
  • - Review Article

Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses

Julia Kim | Vandana Gambhir | ... | Sameh Basta
  • Special Issue
  • - Volume 2010
  • - Article ID 798467
  • - Research Article

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Joris D. Veltman | Margaretha E. H. Lambers | ... | Joost P. J. J. Hegmans
  • Special Issue
  • - Volume 2010
  • - Article ID 263810
  • - Review Article

Immune Response of Cytotoxic T Lymphocytes and Possibility of Vaccine Development for Hepatitis C Virus Infection

Kazumasa Hiroishi | Junichi Eguchi | ... | Michio Imawari
  • Special Issue
  • - Volume 2010
  • - Article ID 534501
  • - Research Article

Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice

Donatella R. M. Negri | Zuleika Michelini | ... | Andrea Cara
  • Special Issue
  • - Volume 2010
  • - Article ID 641757
  • - Review Article

Regulation of the Induction and Function of Cytotoxic T Lymphocytes by Natural Killer T Cell

Hiroyasu Ito | Mitsuru Seishima
  • Special Issue
  • - Volume 2010
  • - Article ID 705431
  • - Research Article

Endoplasmic Reticulum Stress-Mediated Apoptosis Involved in Indirect Recognition Pathway Blockade Induces Long-Term Heart Allograft Survival

Jianbin Xiang | Xiaodong Gu | ... | Zongyou Chen
  • Special Issue
  • - Volume 2010
  • - Article ID 270985
  • - Research Article

Autocrine, Not Paracrine, Interferon-Gamma Gene Delivery Enhances Ex Vivo Antigen-Specific Cytotoxic T Lymphocyte Stimulation and Killing

Dazhi Zhang | Yong Liu | ... | Paul L. Hermonat
  • Special Issue
  • - Volume 2010
  • - Article ID 521248
  • - Review Article

Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia

Toshiki Ochi | Hiroshi Fujiwara | Masaki Yasukawa
  • Special Issue
  • - Volume 2010
  • - Article ID 956304
  • - Review Article

Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer

Marc Cartellieri | Michael Bachmann | ... | Marc Schmitz
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.